Oligopeptide complex for targeted non-viral gene delivery to adipocytes.

Commercial anti-obesity drugs acting in the gastrointestinal tract or the central nervous system have been shown to have limited efficacy and severe side effects. Anti-obesity drug development is thus focusing on targeting adipocytes that store excess fat. Here, we show that an adipocyte-targeting fusion-oligopeptide gene carrier consisting of an adipocyte-targeting sequence and 9-arginine (ATS-9R) selectively transfects mature adipocytes by binding to prohibitin. Injection of ATS-9R into obese mice confirmed specific binding of ATS-9R to fat vasculature, internalization and gene expression in adipocytes. We also constructed a short-hairpin RNA (shRNA) for silencing fatty-acid-binding protein 4 (shFABP4), a key lipid chaperone in fatty-acid uptake and lipid storage in adipocytes. Treatment of obese mice with ATS-9R/shFABP4 led to metabolic recovery and body-weight reduction (>20%). The ATS-9R/shFABP4 oligopeptide complex could prove to be a safe therapeutic approach to regress and treat obesity as well as obesity-induced metabolic syndromes.

[1]  Didier Merlin,et al.  Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. , 2010, Nature materials.

[2]  D. Geerts,et al.  RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics , 2016, Oncotarget.

[3]  E. Mariman,et al.  Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines , 2004, Cellular and Molecular Life Sciences CMLS.

[4]  S. W. Kim,et al.  Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. , 2009, Biomaterials.

[5]  Amita Sharma,et al.  Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Katagiri,et al.  Regulation of PPARγ transcriptional activity in 3T3-L1 adipocytes , 2003 .

[7]  H. Katagiri,et al.  Regulation of PPAR gamma transcriptional activity in 3T3-L1 adipocytes. , 2003, Biochemical and biophysical research communications.

[8]  R. Ahima.  Central actions of adipocyte hormones , 2005, Trends in Endocrinology & Metabolism.

[9]  S. Cinti,et al.  The adipose organ. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[10]  E. Vázquez,et al.  Peptide-assisted traffic engineering for nonviral gene therapy. , 2008, Drug discovery today.

[11]  M. Furuhashi,et al.  Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets , 2008, Nature Reviews Drug Discovery.

[12]  M. Tankersley,et al.  T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice , 2009, Pediatrics.

[13]  L. Moldawer,et al.  Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study , 2001, Regulatory Peptides.

[14]  T. Park,et al.  Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. , 2010, Nature materials.

[15]  Young-Wook Won,et al.  Poly(oligo-D-arginine) with internal disulfide linkages as a cytoplasm-sensitive carrier for siRNA delivery. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  C. Newgard,et al.  Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Minhyung Lee,et al.  Reducible poly(oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  P. Scherer,et al.  Keynote review: the adipocyte as a drug discovery target. , 2005, Drug discovery today.

[19]  M. C. Cardoso,et al.  Cell Entry of Arginine-rich Peptides Is Independent of Endocytosis*S⃞ , 2009, Journal of Biological Chemistry.

[20]  M. During,et al.  Molecular therapy of obesity and diabetes by a physiological autoregulatory approach , 2009, Nature Medicine.

[21]  Dunstan Cooke,et al.  The obesity pipeline: current strategies in the development of anti-obesity drugs , 2006, Nature Reviews Drug Discovery.

[22]  L. Murphy,et al.  Prohibitin: a potential target for new therapeutics. , 2005, Trends in molecular medicine.

[23]  S. Bonner-Weir,et al.  Improved glucose and lipid metabolism in genetically obese mice lacking aP2. , 2000, Endocrinology.

[24]  V. Dixit,et al.  Adipose tissue as an immunological organ , 2015, Obesity.

[25]  T. C. Whitmore,et al.  Long-term study , 1991, Nature.

[26]  Wadih Arap,et al.  Reversal of obesity by targeted ablation of adipose tissue , 2004, Nature Medicine.

[27]  Forrest M Kievit,et al.  Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. , 2011, Biomaterials.

[28]  C. Elangbam.  Review Paper: Current Strategies in the Development of Anti-obesity Drugs and Their Safety Concerns , 2009, Veterinary pathology.

[29]  Minhyung Lee,et al.  Therapeutic effects of a reducible poly (oligo-D-arginine) carrier with the heme oxygenase-1 gene in the treatment of hypoxic-ischemic brain injury. , 2010, Biomaterials.

[30]  P. Strålfors,et al.  Human, but not rat, IRS1 targets to the plasma membrane in both human and rat adipocytes. , 2007, Biochemical and biophysical research communications.

[31]  J. Feijen,et al.  Reducible poly(amido ethylenimine)-based gene delivery system for improved nucleus trafficking of plasmid DNA. , 2010, Bioconjugate chemistry.

[32]  K. Walsh,et al.  Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.

[33]  B. Zetter,et al.  Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells , 2010, Proceedings of the National Academy of Sciences.

[34]  Bruce M. Spiegelman,et al.  Adipocytes as regulators of energy balance and glucose homeostasis , 2006, Nature.